ENVB - Company ID 0000890821
Enveric Biosciences, Inc. (ENVB) reported net income of $12.10M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | $12.10M | +26.0% |
| FY 2024 | $9.60M | -45.1% |
| FY 2023 | $17.50M | +194.7% |
| FY 2022 | -$18.47M | +62.3% |
| FY 2021 | -$48.98M | -613.5% |
| FY 2020 | -$6.86M | -184.8% |
| FY 2019 | -$2.41M | +85.7% |
| FY 2018 | -$16.90M | -86.2% |
| FY 2017 |
Enveric Biosciences, Inc. (ENVB) reported net income of $12.10M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, Enveric Biosciences, Inc.'s net income grew from -$33.38K to $12.10M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$9.07M |
| -226.4% |
| FY 2016 | -$2.78M | -241.6% |
| FY 2015 | -$814.08K | -2319.7% |
| FY 2014 | -$33.64K | -20796.9% |
| FY 2013 | -$161.00 | +99.3% |
| FY 2012 | -$24.62K | +26.2% |
| FY 2011 | -$33.38K | - |